Betrixaban
Betrixaban
Betrixaban (pronounced as be-trix-a-ban) is an anticoagulant medication used to prevent venous thromboembolism in adults. It is classified under the drug class of Factor Xa inhibitors.
Etymology
The name 'Betrixaban' is derived from its chemical structure. The 'b' stands for benzamidine, the 'e' for ethyl, the 'trix' for triazolopyridinone, and the 'aban' for aminobenzamidine.
Usage
Betrixaban is primarily used for the prevention of venous thromboembolism (VTE) in adults hospitalized for an acute medical illness who are at risk for thromboembolic complications due to moderate or severe restricted mobility and other risk factors for VTE.
Mechanism of Action
Betrixaban works by inhibiting Factor Xa, an enzyme that plays a key role in blood clotting. By blocking this enzyme, betrixaban prevents the formation of blood clots.
Related Terms
Side Effects
Common side effects of betrixaban include bleeding, anemia, and low platelet count. Serious side effects may include spinal or epidural hematoma, which can cause long-term or permanent paralysis.
Precautions
Patients with active pathological bleeding or severe hypersensitivity reaction to betrixaban should not use this medication. It should be used with caution in patients with renal or hepatic impairment.
Interactions
Betrixaban can interact with other medications, including other anticoagulants, antiplatelet drugs, and certain types of antidepressants. It is important to inform your healthcare provider about all the medications you are currently taking before starting betrixaban.
External links
- Medical encyclopedia article on Betrixaban
- Wikipedia's article - Betrixaban
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski